ANIK Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Anika Therapeutics Inc

Watchlist Manager

Watchlist

Price: 15.6 USD -3.05% Market Closed

Market Cap: $207.6m

	Anika Therapeutics Inc NASDAQ:ANIK	US
C	Continental AG SWB:CON	DE
O	Ovh Groupe SA PAR:OVH	FR
	Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	CN
	Prosegur Compania de Seguridad SA MAD:PSG	ES
T	Toyota Motor Corp BMV:TMN	JP
M	Murata Manufacturing Co Ltd SWB:MUR1	JP
	Alpha Systems Inc F:AN5	JP
L	Live Oak Bancshares Inc NYSE:LOB	US
N	Novo Nordisk A/S SWB:NOVA	DK
	Tata Power Company Ltd BSE:500400	IN
C	Campbell Soup Co DUS:CSC	US
H	Henkel AG & Co KGaA DUS:HEN	DE
P	PGE Polska Grupa Energetyczna SA WSE:PGE	PL
R	Rai Way SpA LSE:0R40	IT
S	SPCG PCL SET:SPCG	TH

Profitability Summary

Anika Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

59%

Strong 3Y Average Gross Margin

61%

Declining Gross Margin

61% > 59%

Negative Operating Margin

-9%

Negative 3Y Average Operating Margin

-7%

Operating Margin is Increasing

-14% > -9%

Negative Net Margin

-10%

Negative 3Y Average Net Margin

-36%

Net Margin is Increasing

-14% > -10%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-2%

Free Cash Flow Margin is Increasing

-10% > 1%

Negative ROE

-8%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-7%

Declining ROIC

-7% > -9%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.